Efficacy of vacuum assisted closure therapy for preventing drive-line infections after left ventricular assist device implantaion.

Efficacy of vacuum assisted closure therapy for preventing drive-line infections after left ventricular assist device implantaion. - Efficacy of VAC therapy for preventing DLI after LVAD implantation.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032458

Enrollment

Registered

2018-05-02

Start date

2018-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced heart failure

Interventions

Vacuum assisted closure therapy is performed for the drive-line wound site for 7 days after left ventricular assist device implantation.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patient who undergoes implantation of left ventricular assist device as bridge to transplantation. 2) 16 years old or older. 3) Patient who understands the purpose of this study and consents the entry.

Exclusion criteria

Exclusion criteria: 1) Patients who have uncontrollable infections. 2) Patients who have a tendency to bleed in drive-line wound site. 3) Patients who are difficult to close the wound by vacuum assisted closure device. 4) Patients who have an allergy to foam. 5) Patients researchers have determined to be inappropriate.

Design outcomes

Primary

Measure	Time frame
Primary outcome is drive-line infections(DLI) defined as clinical evidence of DLI accompanied by a positive bacterial swab and need for antibiotics.	—

Countries

Japan

Contacts

Public ContactMasaki Masaki

Graduate School of Medicine, University of Tokyo Department of Cardiovascular Medicine

TSUJIM-INT@h.u-tokyo.ac.jp03-5800-8855

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026